Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
283.193614427
InChI
InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18+,19+/m0/s1
InChI Key
InChIKey=OZYUPQUCAUTOBP-QXAKKESOSA-N
IUPAC Name
(1R,9R,10R)-17-(prop-2-en-1-yl)-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-trien-4-ol
Traditional IUPAC Name
levallorphan
SMILES
[H][C@@]12CCCC[C@@]11CCN(CC=C)[C@@H]2CC2=C1C=C(O)C=C2
pKa (strongest acidic)
10.36
pKa (Strongest Basic)
9.41
Refractivity
87.24 m3·mol-1
Dược Lực Học :
Levallorphan, an opioid antagonist similar to naloxone, is used to treat drug overdoses. Levallorphan differs from naloxone in that it also possesses some agonist properties. It is an analogue of levelorphanol that counteracts the actions of narcotic analgesics such as morphine. It is used especially in the treatment of respiratory depression due to narcotic overdoses. Levallorphan prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension. Also, it can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine.
Cơ Chế Tác Dụng :
An opioid antagonist with properties similar to those of naloxone; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683)
Levallorphan antagonizes opioid effects by competing for the same receptor sites. It binds to the opioid mu receptor and the nicotinic acetylcholine receptor alpha2/alpha3.
Dược Động Học :
▧ Absorption :
Rapidly absorbed.
▧ Metabolism :
Hepatic.
▧ Half Life :
1 hour
Độc Tính :
Oral, rat LD50: 109±4 mg/kg
Chỉ Định :
For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids.